Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events

Circulation

Volumn 109, Issue 12, 2004, Pages 1497-1502

  Lazar, Harold L ^a,c   Chipkin, Stuart R ^b   Fitzgerald, Carmel A ^a   Bao, Yusheng ^a   Cabral, Howard ^a   Apstein, Carl S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Insulin; Ischemia

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM CHLORIDE;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FEMALE; FLUID THERAPY; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HUMAN; INSULIN TREATMENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; WOUND INFECTION;

ATRIAL FIBRILLATION; BLOOD GLUCOSE; CARDIOPLEGIC SOLUTIONS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; HUMANS; INSULIN; LACTATES; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POTASSIUM; RECURRENCE; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 1842434301     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000121747.71054.79     Document Type: Article

References (25)

1. Szabo Z, Hakanson E, Svedjeholm R. Early post-operative outcome and medium-term survival in 540 diabetic and 2239 non-diabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2002;74:712-719.
2. Cohen Y. Raz I, Merin G, et al. Comparison of factors associated with 30 day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Am J Cardiol. 1998;81:7-11.
3. Carson JL, Scholz PM, Chen AY, et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40:418-423.
4. Jacoby R, Nesto R. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol. 1992;20:736-744.
5. Malmberg K, Ryden L, Egendic S. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
6. DIGAMI Study Group. Prospective randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. Br Med J. 1997;314:1512-1515.
7. Lazar HL, Chipkin S, Philippides G, et al. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg. 2000;70:145-150.
8. Liu G, Docherty JC, Rendell JCT, et al. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol. 2002;39:718-725.
9. Svensson S, Svedjeholm R, Ekroth R. Trauma metabolism of the heart: uptake of substrates and effects of insulin early after cardiac operations. J Thorac Cardiovasc Surg. 1990;99:1063-1073.
10. Abdella N, Mosimineyi O, Moussa M. Case control study of C-reactive protein with coronary heart disease in patients with type 2 diabetes mellitus. Diabetes. 2002;51 (suppl 2):1165-1166.
11. Hotamisligil GS, Arner P, Caro JF. Increased adipose tissue expression of tumor necrosis factor in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-2415.
12. Guerci B, Bohme P, Kearney-Schwartz A, et al. Endothelial dysfunction and type 2 diabetes. Diabetes Metab. 2001;27:436-447.
13. Verma S, Maitland A, Weisel RD, et al. Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism. J Thorac Cardiovasc Surg. 2002;123:1120-1124.
14. Guzik TJ, Mussa S, Gastaldi D, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD (1)H oxidase and endothelial nitric oxide synthase. Circulation. 2001;105:1656-1662.
15. Davi G, Catalan I, Avema M. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 1990;322:1769-1774.
16. Marfella R, Esposito K, Gionta R, et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation. 2000;101:2247-2251.
17. Rao V, Merante F, Weisel RD, et al. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia. J Thorac Cardiovasc Surg. 1998;116:485-494.
18. Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kB and stimulates kB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect. J Clin Endocrinol Metab. 2001;86:3257-3265.
19. Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002;40:1748-1754.
20. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose: independent risk factor for long-term prognosis after myocardial infarction even in non-diabetic patients. Diabetes Care. 1999;11:1827-1831.
21. Iwakura K, Ito H, Ikoshima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1-7.
22. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
23. Fath-Houbadi F, Beatt JK. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152-1156.
24. VandenBerghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
25. Gao F, Gao E, Yue T-L, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of P13-kinase, AKT, and endothelial nitric-oxide synthase phosphorylation. Circulation. 2002;105:1497-1502.